CDKN2A and neoplasm: Key genetic drivers include KRAS mutations, found in about 95% of PDAC cases, which activate growth and survival pathways, along with mutations in tumor suppressor genes like TP53, CDKN2A (p16), and SMAD4, causing uncontrolled cell growth, avoidance of cell death, and tumor development [10,11].